![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 24813 |
FusionGeneSummary for NR6A1_ATF3 |
![]() |
Fusion gene information | Fusion gene name: NR6A1_ATF3 | Fusion gene ID: 24813 | Hgene | Tgene | Gene symbol | NR6A1 | ATF3 | Gene ID | 2649 | 467 |
Gene name | nuclear receptor subfamily 6 group A member 1 | activating transcription factor 3 | |
Synonyms | CT150|GCNF|GCNF1|NR61|RTR|hGCNF|hRTR | - | |
Cytomap | 9q33.3 | 1q32.3 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear receptor subfamily 6 group A member 1germ cell nuclear factor variant 1retinoic acid receptor-related testis-associated receptorretinoid receptor-related testis-specific receptor | cyclic AMP-dependent transcription factor ATF-3cAMP-dependent transcription factor ATF-3 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q15406 | P18847 | |
Ensembl transtripts involved in fusion gene | ENST00000487099, ENST00000373584, ENST00000416460, ENST00000344523, | ENST00000366987, ENST00000341491, ENST00000366985, ENST00000492118, ENST00000336937, ENST00000366983, | |
Fusion gene scores | * DoF score | 3 X 3 X 4=36 | 4 X 4 X 2=32 |
# samples | 4 | 4 | |
** MAII score | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: NR6A1 [Title/Abstract] AND ATF3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ATF3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 8622660 |
Tgene | ATF3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 16300731 |
Tgene | ATF3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 24939851 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BF853631 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000487099 | ENST00000366987 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000487099 | ENST00000341491 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000487099 | ENST00000366985 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-3UTR | ENST00000487099 | ENST00000492118 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000487099 | ENST00000336937 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000487099 | ENST00000366983 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000373584 | ENST00000366987 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000373584 | ENST00000341491 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000373584 | ENST00000366985 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-3UTR | ENST00000373584 | ENST00000492118 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000373584 | ENST00000336937 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000373584 | ENST00000366983 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000416460 | ENST00000366987 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000416460 | ENST00000341491 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000416460 | ENST00000366985 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-3UTR | ENST00000416460 | ENST00000492118 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000416460 | ENST00000336937 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000416460 | ENST00000366983 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000344523 | ENST00000366987 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000344523 | ENST00000341491 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000344523 | ENST00000366985 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-3UTR | ENST00000344523 | ENST00000492118 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000344523 | ENST00000336937 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
intron-intron | ENST00000344523 | ENST00000366983 | NR6A1 | chr9 | 127441085 | - | ATF3 | chr1 | 212786881 | + |
Top |
FusionProtFeatures for NR6A1_ATF3 |
![]() |
Hgene | Tgene |
NR6A1 | ATF3 |
Orphan nuclear receptor. Binds to a response elementcontaining the sequence 5'-TCAAGGTCA-3'. May be involved in theregulation of gene expression in germ cell development duringgametogenesis (By similarity). {ECO:0000250}. | This protein binds the cAMP response element (CRE)(consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in manyviral and cellular promoters. Represses transcription frompromoters with ATF sites. It may repress transcription bystabilizing the binding of inhibitory cofactors at the promoter.Isoform 2 activates transcription presumably by sequesteringinhibitory cofactors away from the promoters. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NR6A1_ATF3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NR6A1_ATF3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NR6A1_ATF3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NR6A1_ATF3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ATF3 | C0027765 | nervous system disorder | 2 | CTD_human |
Tgene | ATF3 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | ATF3 | C0011570 | Mental Depression | 1 | PSYGENET |
Tgene | ATF3 | C0011581 | Depressive disorder | 1 | PSYGENET |
Tgene | ATF3 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Tgene | ATF3 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Tgene | ATF3 | C0021400 | Influenza | 1 | CTD_human |
Tgene | ATF3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | ATF3 | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | ATF3 | C0031117 | Peripheral Neuropathy | 1 | CTD_human |
Tgene | ATF3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | ATF3 | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human |
Tgene | ATF3 | C0848558 | Hypospadias | 1 | CTD_human |
Tgene | ATF3 | C0878544 | Cardiomyopathies | 1 | CTD_human |
Tgene | ATF3 | C0919267 | ovarian neoplasm | 1 | CTD_human |